Form 4: PMV Pharmaceuticals CEO Sells Shares for Tax Obligations, Maintains Significant Holdings

PMV Pharmaceuticals' President and CEO, David Henry Mack, sold 58,411 shares of common stock to cover tax obligations related to restricted stock unit vesting, while retaining substantial direct and indirect ownership.

Summary

• David Henry Mack, President and CEO of PMV Pharmaceuticals, Inc. (PMVP), reported a transaction on July 1, 2025.
• A total of 58,411 shares of common stock were sold at a price of $1.0645 per share.
• The sale was conducted to satisfy tax obligations incurred from the vesting of restricted stock units (RSUs).
• Following the transaction, David Henry Mack directly beneficially owns 536,133 shares of common stock.
• Direct holdings include 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025.
• Indirect beneficial ownership includes 165,307 shares held by the Stinson 2021 Irrevocable Trust, 147,915 shares held by the Mack-Mulligan Revocable Trust, and 56,978 shares held by the Mack/Mulligan 2020 Irrevocable Descendants' Trust.

Sentiment

Score: 6

Explanation: The transaction is a routine tax-related sale by an executive, which is a common occurrence and not typically indicative of negative sentiment towards the company. The acquisition of shares via an ESPP also shows continued investment.

Positives

• The reporting person acquired 15,528 shares under the Issuer's Employee Stock Purchase Plan on May 15, 2025, indicating continued investment in the company.

Negatives

• The President and CEO sold 58,411 shares of common stock, although this was explicitly stated to be for tax obligations related to RSU vesting, a common practice.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Shares are held indirectly by the Stinson 2021 Irrevocable Trust (165,307 shares), the Mack-Mulligan Revocable Trust (147,915 shares), and the Mack/Mulligan 2020 Irrevocable Descendants' Trust (56,978 shares). The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.

Stakeholder Impact

• Shareholders: A routine sale of shares by a key executive to cover tax obligations, which is a common practice and generally not indicative of a change in company outlook.
• Employees: The acquisition of shares through the Employee Stock Purchase Plan indicates continued participation in company equity programs.

Key Dates

Recommendation

Keywords

PMV Pharmaceuticals, PMVP, Form 4, Insider Transaction, Stock Sale, RSU Vesting, Employee Stock Purchase Plan, David Henry Mack